Filing Details
- Accession Number:
- 0000950170-25-020376
- Form Type:
- 13G Filing
- Publication Date:
- 2025-02-13 19:00:00
- Filed By:
- Tony Xu Han
- Company:
- Weride Inc.
- Filing Date:
- 2025-02-14
- SEC Url:
- 13G Filing
Ownership Summary
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
Name | Beneficially Owned Number of Shares | Beneficially Owned Number of Aggregate Shares | Percent of Class |
---|---|---|---|
Tony Xu Han | 0 | 59,402,393 | 7.2% |
Tonyhan Limited | 0 | 16,399,590 | 2.1% |
Xu Han Limited | 0 | 24,850,000 | 3.1% |
Filing
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13G
|
UNDER THE SECURITIES EXCHANGE ACT OF 1934
|
WeRide Inc. (Name of Issuer) |
Class A ordinary shares, par value US$0.00001 per share (Title of Class of Securities) |
950915108 (CUSIP Number) |
12/31/2024 (Date of Event Which Requires Filing of this Statement) |
Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |
![]() |
![]() |
![]() |
SCHEDULE 13G
|
CUSIP No. | 950915108 |
1 | Names of Reporting Persons
Tony Xu Han | ||||||||
2 | Check the appropriate box if a member of a Group (see instructions)
![]() ![]() | ||||||||
3 | Sec Use Only | ||||||||
4 | Citizenship or Place of Organization
CHINA
| ||||||||
Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
9 | Aggregate Amount Beneficially Owned by Each Reporting Person
59,402,393.00 | ||||||||
10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
![]() | ||||||||
11 | Percent of class represented by amount in row (9)
7.2 % | ||||||||
12 | Type of Reporting Person (See Instructions)
IN |
Comment for Type of Reporting Person: Note to Row (2)(b): The reporting person has entered into a nominating and support agreement with the issuer, Dr. Yan Li, and Alliance Ventures, B.V., which provides for Alliance Ventures, B.V. to appoint, remove, and replace two directors of the issuer subject to certain conditions. The reporting person expressly disclaims the existence of a group with Dr. Yan Li or Alliance Ventures, B.V.
Note to Row (5), (7) and (9): Represents (i) 16,399,590 Class B ordinary shares held by Tonyhan Limited, (ii) 24,850,000 Class B ordinary shares held by Xu Han Limited, and (iii) 18,152,803 Class B ordinary shares Dr. Tony Xu Han has the right to acquire upon exercise of options within 60 days after December 31, 2024. Dr. Tony Xu Han holds 51% equity interests in Tonyhan Limited through Xu Han Limited, which is in turn 100% owned by Dr. Tony Xu Han. Dr. Tony Xu Han is also the sole director of Tonyhan Limited. Pursuant to Section 13(d) of the Securities Exchange Act of 1934, as amended, and the rules promulgated thereunder, Dr. Tony Xu Han may be deemed to beneficially own all of the shares of the issuer owned by each of Tonyhan Limited and Xu Han Limited. Each Class B ordinary share is convertible into one Class A ordinary share. Class A ordinary shares are not convertible into Class B ordinary shares under any circumstances. The registered address of each of Tonyhan Limited and Xu Han Limited is Harkom Corporate Services Limited of Jayla Place, P.O. Box 216, Road Town, Tortola, VG1110, British Virgin Islands.
Note to Row (11): The percentage of the class of securities is calculated by dividing the number of shares beneficially owned by the reporting person by all of the issuer's issued and outstanding Class A ordinary shares and the reporting person's Class B ordinary shares, which can be converted into Class A ordinary shares, as of December 31, 2024.
The shares beneficially owned by the reporting person represents 64.4% of the total outstanding voting power. The percentage of voting power is calculated by dividing the voting power beneficially owned by the reporting person by the voting power beneficially owned by all of the issuer's holders of Class A ordinary shares and Class B ordinary shares as a single class as of December 31, 2024 (taking into account the number of shares that the reporting person had the right to acquire upon exercise of options within 60 days after December 31, 2024). Each holder of the Class A ordinary share is entitled to one vote per share and each holder of the Class B ordinary share is entitled to 40 votes per share.
SCHEDULE 13G
|
CUSIP No. | 950915108 |
1 | Names of Reporting Persons
Tonyhan Limited | ||||||||
2 | Check the appropriate box if a member of a Group (see instructions)
![]() ![]() | ||||||||
3 | Sec Use Only | ||||||||
4 | Citizenship or Place of Organization
VIRGIN ISLANDS, BRITISH
| ||||||||
Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
9 | Aggregate Amount Beneficially Owned by Each Reporting Person
16,399,590.00 | ||||||||
10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
![]() | ||||||||
11 | Percent of class represented by amount in row (9)
2.1 % | ||||||||
12 | Type of Reporting Person (See Instructions)
CO |
Comment for Type of Reporting Person: Note to Row 2(b): Dr. Tony Xu Han, who controls the reporting person, has entered into a nominating and support agreement with the issuer, Dr. Yan Li, and Alliance Ventures, B.V., which provides for Alliance Ventures, B.V. to appoint, remove, and replace two directors of the issuer subject to certain conditions. The reporting person expressly disclaims the existence of a group with Dr. Yan Li or Alliance Ventures, B.V.
Note to Row (5), (7) and (9): Represents 16,399,590 Class B ordinary shares held by Tonyhan Limited. The registered address of Tonyhan Limited is Harkom Corporate Services Limited of Jayla Place, P.O. Box 216, Road Town, Tortola, VG1110, British Virgin Islands.
Note to Row (11): The percentage of the class of securities is calculated by dividing the number of shares beneficially owned by the reporting person by all of the issuer's issued and outstanding Class A ordinary shares and the reporting person's Class B ordinary shares, which can be converted into Class A ordinary shares, as of December 31, 2024.
The shares beneficially owned by the reporting person represents 22.1% of the total outstanding voting power. The percentage of voting power is calculated by dividing the voting power beneficially owned by the reporting person by the voting power beneficially owned by all of the issuer's holders of Class A ordinary shares and Class B ordinary shares as a single class as of December 31, 2024 (taking into account the number of shares that the reporting person had the right to acquire upon exercise of options within 60 days after December 31, 2024). Each holder of the Class A ordinary share is entitled to one vote per share and each holder of the Class B ordinary share is entitled to 40 votes per share.
SCHEDULE 13G
|
CUSIP No. | 950915108 |
1 | Names of Reporting Persons
Xu Han Limited | ||||||||
2 | Check the appropriate box if a member of a Group (see instructions)
![]() ![]() | ||||||||
3 | Sec Use Only | ||||||||
4 | Citizenship or Place of Organization
VIRGIN ISLANDS, BRITISH
| ||||||||
Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
9 | Aggregate Amount Beneficially Owned by Each Reporting Person
24,850,000.00 | ||||||||
10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
![]() | ||||||||
11 | Percent of class represented by amount in row (9)
3.1 % | ||||||||
12 | Type of Reporting Person (See Instructions)
CO |
Comment for Type of Reporting Person: Note to Row (2)(b): Dr. Tony Xu Han, who controls the reporting person, has entered into a nominating and support agreement with the issuer, Dr. Yan Li, and Alliance Ventures, B.V., which provides for Alliance Ventures, B.V. to appoint, remove, and replace two directors of the issuer subject to certain conditions. The reporting person expressly disclaims the existence of a group with Dr. Yan Li or Alliance Ventures, B.V.
Note to Row (5), (7) and (9): Represents 24,850,000 Class B ordinary shares held by Xu Han Limited. The registered address of Xu Han Limited is Harkom Corporate Services Limited of Jayla Place, P.O. Box 216, Road Town, Tortola, VG1110, British Virgin Islands.
Note to Row (11): The percentage of the class of securities is calculated by dividing the number of shares beneficially owned by the reporting person by all of the issuer's issued and outstanding Class A ordinary shares and the reporting person's Class B ordinary shares, which can be converted into Class A ordinary shares, as of December 31, 2024.
The shares beneficially owned by the reporting person represents 33.5% of the total outstanding voting power. The percentage of voting power is calculated by dividing the voting power beneficially owned by the reporting person by the voting power beneficially owned by all of the issuer's holders of Class A ordinary shares and Class B ordinary shares as a single class as of December 31, 2024 (taking into account the number of shares that the reporting person had the right to acquire upon exercise of options within 60 days after December 31, 2024). Each holder of the Class A ordinary share is entitled to one vote per share and each holder of the Class B ordinary share is entitled to 40 votes per share.
SCHEDULE 13G
|
Item 1. | ||
(a) | Name of issuer:
WeRide Inc. | |
(b) | Address of issuer's principal executive offices:
21st Floor, Tower A, No. 51, Luoxuan Road, Guangzhou, China, 510005 | |
Item 2. | ||
(a) | Name of person filing:
Tony Xu Han
Tonyhan Limited
Xu Han Limited | |
(b) | Address or principal business office or, if none, residence:
Tony Xu Han
21st Floor, Tower A, Guanzhou Life Science Innovation Center,
No. 51, Luoxuan Road, Guangzhou International Biotech Island,
Guangzhou, People's Republic of China
Tonyhan Limited
Jayla Place, P.O. Box 216,
Road Town, Tortola, VG1110,
British Virgin Islands
Xu Han Limited
Jayla Place, P.O. Box 216,
Road Town, Tortola, VG1110,
British Virgin Islands | |
(c) | Citizenship:
Tony Xu Han - People's Republic of China
Tonyhan Limited - British Virgin Islands
Xu Han Limited - British Virgin Islands | |
(d) | Title of class of securities:
Class A ordinary shares, par value US$0.00001 per share | |
(e) | CUSIP No.:
950915108 | |
Item 3. | If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: | |
(a) | ![]() | |
(b) | ![]() | |
(c) | ![]() | |
(d) | ![]() | |
(e) | ![]() | |
(f) | ![]() | |
(g) | ![]() | |
(h) | ![]() | |
(i) | ![]() | |
(j) | ![]() please specify the type of institution: | |
(k) | ![]() | |
Item 4. | Ownership | |
(a) | Amount beneficially owned:
Tony Xu Han - 59,402,393*
Tonyhan Limited - 16,399,590**
Xu Han Limited - 24,850,000***
*Represents (i) 16,399,590 Class B ordinary shares held by Tonyhan Limited, a British Virgin Islands company, (ii) 24,850,000 Class B ordinary shares held by Xu Han Limited, a British Virgin Islands company, and (iii) 18,152,803 Class B ordinary shares Dr. Tony Xu Han has the right to acquire upon exercise of options within 60 days after December 31, 2024. Dr. Tony Xu Han holds 51% equity interests in Tonyhan Limited through Xu Han Limited, which is in turn 100% owned by Dr. Tony Xu Han. Dr. Tony Xu Han is also the sole director of Tonyhan Limited. Pursuant to Section 13(d) of the Securities Exchange Act of 1934, as amended, and the rules promulgated thereunder, Dr. Tony Xu Han may be deemed to beneficially own all of the shares of the issuer owned by each of Tonyhan Limited and Xu Han Limited.
** Represents 16,399,590 Class B ordinary shares held by Tonyhan Limited, a British Virgin Islands company.
*** Represents 24,850,000 Class B ordinary shares held by Xu Han Limited, a British Virgin Islands company. | |
(b) | Percent of class:
Tony Xu Han - 7.2%, representing 64.4% of the total outstanding voting power
Tonyhan Limited - 2.1%, representing 22.1% of the total outstanding voting power
Xu Han Limited - 3.1%, representing 33.5% of the total outstanding voting power
The percentage of class of securities beneficially owned by the reporting persons is based on a total of 771,399,682 issued and outstanding Class A ordinary shares and also takes into account Class A ordinary shares that the reporting persons have the right to acquire upon conversion of Class B ordinary shares and upon exercise of options within 60 day after December 31, 2024.
The percentage of voting power is calculated by dividing the voting power beneficially owned by the reporting persons by the voting power of all of the issuer's Class A ordinary shares and Class B ordinary shares as a single class as of December 31, 2024 (taking into account the number of shares that the reporting person had the right to acquire upon exercise of options within 60 days after December 31, 2024). Each holder of the Class A ordinary share is entitled to one vote per share and each holder of the Class B ordinary share is entitled to 40 votes per share. | |
(c) | Number of shares as to which the person has:
| |
(i) Sole power to vote or to direct the vote:
Tony Xu Han - 59,402,393*
Tonyhan Limited - 16,399,590**
Xu Han Limited - 24,850,000***
*Represents (i) 16,399,590 Class B ordinary shares held by Tonyhan Limited, a British Virgin Islands company, (ii) 24,850,000 Class B ordinary shares held by Xu Han Limited, a British Virgin Islands company, and (iii) 18,152,803 Class B ordinary shares Dr. Tony Xu Han has the right to acquire upon exercise of options within 60 days after December 31, 2024. Dr. Tony Xu Han holds 51% equity interests in Tonyhan Limited through Xu Han Limited, which is in turn 100% owned by Dr. Tony Xu Han. Dr. Tony Xu Han is also the sole director of Tonyhan Limited. Pursuant to Section 13(d) of the Securities Exchange Act of 1934, as amended, and the rules promulgated thereunder, Dr. Tony Xu Han may be deemed to beneficially own all of the shares of the issuer owned by each of Tonyhan Limited and Xu Han Limited.
** Represents 16,399,590 Class B ordinary shares held by Tonyhan Limited, a British Virgin Islands company.
*** Represents 24,850,000 Class B ordinary shares held by Xu Han Limited, a British Virgin Islands company. | ||
(ii) Shared power to vote or to direct the vote:
Tony Xu Han - 0
Tonyhan Limited - 0
Xu Han Limited - 0 | ||
(iii) Sole power to dispose or to direct the disposition of:
Tony Xu Han - 59,402,393*
Tonyhan Limited - 16,399,590**
Xu Han Limited - 24,850,000***
*Represents (i) 16,399,590 Class B ordinary shares held by Tonyhan Limited, a British Virgin Islands company, (ii) 24,850,000 Class B ordinary shares held by Xu Han Limited, a British Virgin Islands company, and (iii) 18,152,803 Class B ordinary shares Dr. Tony Xu Han has the right to acquire upon exercise of options within 60 days after December 31, 2024. Dr. Tony Xu Han holds 51% equity interests in Tonyhan Limited through Xu Han Limited, which is in turn 100% owned by Dr. Tony Xu Han. Dr. Tony Xu Han is also the sole director of Tonyhan Limited. Pursuant to Section 13(d) of the Securities Exchange Act of 1934, as amended, and the rules promulgated thereunder, Dr. Tony Xu Han may be deemed to beneficially own all of the shares of the issuer owned by each of Tonyhan Limited and Xu Han Limited.
** Represents 16,399,590 Class B ordinary shares held by Tonyhan Limited, a British Virgin Islands company.
*** Represents 24,850,000 Class B ordinary shares held by Xu Han Limited, a British Virgin Islands company. | ||
(iv) Shared power to dispose or to direct the disposition of:
Tony Xu Han - 0
Tonyhan Limited - 0
Xu Han Limited - 0 | ||
Item 5. | Ownership of 5 Percent or Less of a Class. | |
Item 6. | Ownership of more than 5 Percent on Behalf of Another Person. | |
Not Applicable
| ||
Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. | |
Not Applicable
| ||
Item 8. | Identification and Classification of Members of the Group. | |
Not Applicable
| ||
Item 9. | Notice of Dissolution of Group. | |
Not Applicable
|
Item 10. | Certifications: |
Not Applicable
|
SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|
|
|
|
|
Exhibit Information
|
Exhibit 99.1 - Joint Filing Agreement |